Navigation Links
Mirixa Announces Agreement With the Pharmacy Guild of Australia
Date:10/14/2008

MirixaPro(SM) chosen to enable patient care services in Australia through

retail pharmacies nationwide

TAMPA, Fla., Oct. 14 /PRNewswire/ -- NCPA 110th Annual Convention -- Mirixa Corporation, the leader in pharmacy-based patient care services and healthlinks.net, a subsidiary of the Pharmacy Guild of Australia, announced today that they have signed a definitive technology licensing and business consulting agreement, paving the way for the use of MirixaPro(SM) in Australia's pharmacies nationwide. Mirixa Australia, a newly formed business venture, will be operated by the Guild's healthlinks.net subsidiary.

Under the agreement, Mirixa, which is sponsored by the National Community Pharmacists Association (NCPA), will adapt and license its widely used web-based software, MirixaPro(SM), for use by pharmacies in Australia. Additionally, Mirixa's success and leadership in enabling patient care services, through its U.S. network of 46,000 contracted pharmacies, will be leveraged by the Guild as it builds its Australian national program. The Guild will initially deploy Mirixa technology and services to facilitate improved medication adherence and outcomes via programs that harness the power of the pharmacist-patient relationship.

"Medication non-adherence is a challenging and complex global problem that results in poor health and increased health care costs," said Kos Sclavos, National President of the Pharmacy Guild of Australia. "After investigating several options, it became clear that Mirixa's experience and advanced technology provide us with the ability to quickly introduce programs that improve medication adherence and healthcare outcomes in Australia. We are looking forward to working with the Mirixa team to bring technology-enabled services to pharmacists and their patients across Australia," added Mr. Sclavos.

"The partnership between Mirixa and the Pharmacy Guild of Australia is a culmination of years of co
'/>"/>

SOURCE Mirixa Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Mirixa Corporation and the APhA Foundation Form Partnership
2. Nile Therapeutics Announces Positive Interim Data from Phase 2a Study of CD-NP in Patients with Heart Failure
3. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
4. WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance
5. Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program
6. CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved
7. Video: Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
8. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
9. China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
10. Pathwork Diagnostics Announces Key Additions to Management Team
11. The Michigan Life Sciences Pipeline Announces The Funding Place(TM) and Other Resources to Connect Investors and Startups
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
(Date:12/19/2014)... 18, 2014 BioPlus Specialty ... specialty pharmacies, has an expanded team of Regional ... consultants for prescriber offices in their regions, with ... “We have a variety of Regional Pharmaceutical Care ... specializing in hepatitis C help prescribers understand all ...
(Date:12/19/2014)... MA (PRWEB) December 18, 2014 iLab ... announced the appointment of Siri Bryant as the new ... new Director of Core Implementations. These two new leadership ... outstanding customer service by ensuring that iLab continues to ... “In the last four years, iLab has been deployed ...
(Date:12/19/2014)... MILLBROOK, N.Y. , Dec. 18, 2014 Egenix, ... has been elected Chairman of the Board, to succeed ... President and CEO, but will continue as a member of ... that he has added to the company over almost twenty ... The Board of Directors has established a Search ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 2BioPlus Specialty Pharmacy Expands ‘Regional Pharmaceutical Care Liaison’ Team 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2
... Calif., July 7, 2011 InterMune (NASDAQ: ... in ASCEND, a new Phase 3 study of pirfenidone ...  ASCEND is a multinational, randomized, double-blind, placebo controlled Phase ... of Esbriet® (pirfenidone) in IPF patients with mild to ...
... America, Inc . ( www.cordblood-america.com ) (OTC Bulletin Board: ... preservation company focused on bringing the life saving potential ... today that CorCell, its domestic brand for cord blood stem ... Rewards Program in the U.S. for the collection of a ...
... a.m. EDT, the space shuttle Atlantis will streak skyward from ... mission. While the STS-135 flight marks the end of the ... new era of research into infectious diseases, thanks to space ... III, along with their colleagues at Arizona State University,s Biodesign ...
Cached Biology Technology:InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 2InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 3InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 4InterMune Initiates Phase 3 ASCEND Study of Pirfenidone in IPF 5CorCell, a Cord Blood America Company, Launches Referral Rewards Program 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 2Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 3Final countdown: Atlantis to carry next-generation vaccine candidate on last space voyage 4
(Date:12/17/2014)... , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ... is accurate, flexible and robust – with the clinical ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience ... international borders. Over the past decade, ePassports, biometric ... travelers to self process through border control via ... an increasing number of airports, seaports, and land ... to Maxine Most , Principal at Acuity ...
(Date:12/11/2014)... Research and Markets , ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ...  report to their offering. One ... in technology. With continuous advances in technology, it ... latest standard that meets the needs and expectations ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... Munich, Germany March 2, 2009 >> Genomatix Software, ... of Next Generation Sequencing (NGS) data, announced today that ... Genomatix Mining Station and a Genomatix Genome Analyzer at ... deliver the only complete and integrated analysis solution for ...
... An international team of scientists, led by Monash University ... kills elderly hospital patients worldwide - a discovery that ... systems billions of dollars each year. The research ... , unravelled ways to genetically modify the bacterium ...
... a picky preschooler who,s avoiding their vegetables? A new Cornell ... like X-Ray Vision Carrots and Tomato Bursts left preschoolers ... carrots called "X-ray Vision Carrots" ate nearly twice as much ... simply labeled as "carrots." The Robert Wood Johnson-funded study also ...
Cached Biology News:Boehringer Ingelheim uses Genomatix' Next Generation Sequencing data analysis systems 2Monash scientists debug superbug 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
... histochemically detect specific senescence ... in cultured cells and ... marker is only present ... found in presenescent/quiescent/immortal cells. ...
TAR DNA binding protein...
... BL21 Star strains are ... for improved protein yield ... systems (Figure 1). Because ... synthesizes mRNA more rapidly ...
Biology Products: